Bridgehead International appoints Marcus Deans
pharmafile | September 26, 2011 | Appointment | Sales and Marketing | appointment, sales and marketing
London-based consultants Bridgehead International have appointed Marcus Deans as principal consultant.
He joins the firm, which specialises in market access, pricing and reimbursement issue, from Takeda where for the past two years he has been a European pricing and market access consultant.
During his 15-year industry career Marcus has also has held a number of leadership positions at both a global and European level, having previously been head of European CNS (Strategic Marketing) and global brand director at Novartis.
Bridgehead International’s chief executive Timothy Fitzgerald said: “We are delighted to welcome Marcus to the company. He brings precisely the mix of expertise and experience that our clients need.”
Related Content

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

Abbott CEO to step down after 21 years
After more than two decades at the head of the company, it has emerged that …






